Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
What will be the peak sales of Genentech's oncology pipeline by December 31, 2025?  | Categorical | 3 | 3 months ago | ||
Will Genentech's RGT-4198 CDK inhibitor progress to Phase 2 clinical trials by September 30, 2025? | Binary | 2 | 3 months ago | ||
Will Genentech's RGT-4198 CDK inhibitor receive FDA Breakthrough Therapy designation by September 30, 2025? | Binary | 2 | 3 months ago | ||
Will Genentech's oncology pipeline achieve projected peak sales of $3.6 billion by December 31, 2025? | Binary | 2 | 3 months ago | ||
What will be the clinical trial outcome for Genentech's RGT-4198 CDK inhibitor by December 31, 2025? | Categorical | 2 | 3 months ago | ||
What regulatory designation will Genentech's RGT-4198 CDK inhibitor receive by September 30, 2025? | Categorical | 2 | 3 months ago |